Statement from Journal of Pharmaceutical Research on Resisting Academic Misconduct
Academic misconduct such as fabricating and tampering with data, plagiarism, duplicate publication, false authorship, and submitting multiple manuscripts not only violates academic norms and ethics, but also goes against relevant national laws and regulations, causing adverse effects in the academic community and even society. In order to strengthen the ethical norms of science and technology and promote scientific research integrity, the editorial department of this journal strictly abides by relevant laws and regulations such as the Copyright Law of the People's Republic of China, and resolutely opposes academic misconduct. The editorial department will use the "Science and Technology Journal Academic Misconduct Document Detection System" of China National Knowledge Infrastructure to detect academic misconduct such as plagiarism, multiple submissions, and forgery in all submissions. If the similarity rate between the submission and the already published article exceeds 20%, the journal will reject the submission.
For papers ultimately identified as academic misconduct, this journal will promptly notify the authors and allow them to provide explanations and defenses before making a final decision on the matter; If the paper has already been officially published, the author of the paper shall be notified in writing to cancel the acceptance qualification of the paper. Duplicate publishers shall send a notice letter to the relevant journal, instructing them to withdraw their submission; If it causes reputation or other losses to this publication, this publication reserves the right to continue seeking compensation. For authors with serious circumstances, the incident shall be reported to the author's unit and other scientific journals in the field; For papers written by authors who commit serious plagiarism or submit multiple manuscripts as the first author, this journal will not accept them within 3 years.